Café

CLNN

5.0150.50%( -0.025 )

LongbridgeAI

CLNN

5.0150.50%( -0.025 )

Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights

Unusual Whales

May 14, 2026 at 07:02 AM

In Salt Lake City on May 14, 2026, Clene Inc. (Nasdaq: CLNN) and its subsidiary Clene Nanomedicine Inc. revealed their Q1 2026 financial results. Clene is a clinical biopharmaceutical company striving to transform the treatment of neurodegenerative ailments like ALS and MS. They highlighted advancements in their CNM-Au8 initiatives.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Clene

USCLNN

-0.50%

CLENE INC C/WTS 30/12/2025 (TO PUR COM)

USCLNNW

LongbridgeAI

Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights

Unusual Whales

May 14, 2026 at 07:02 AM

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

Related Stocks

Clene

USCLNN

-0.50%

CLENE INC C/WTS 30/12/2025 (TO PUR COM)

USCLNNW